static-img-mobile-EN

Satellite Sessions

May 25 | 12:30-14:00

Pfizer Pharmaceuticals Israel | May 25 | 12:30-14:00

Title:ย To screen or not to screen? Pros vs Cons for proactive screening in Rare & Common Heart Diseases

ย 

ย 

Click here to view session agenda.

AstraZeneca (Israel) | May 25 | 12:30-14:00

Title: From HF to CKD and everything in between

ย 

Click here to view session agenda.

May 26 | 12:30-14:00

Abbot Laboratories | May 26 | 12:30-14:00

Title: Structural Heart Therapies- Nurses and Technicians Satellite

ย 

Click here to view session agenda.

Novartis Israel | May 26 | 12:30-14:00

Title: Novel approach in LDL-C management for ASCVD and FH patients- From theory to practice

ย 

Click here to view session agenda.

Bayer Israel | May 26 | 12:30-14:00

Title: What’s next for your HF patients following a Worsening event?

ย 

Click here to view session agenda.

Novo Nordisk | May 26 | 12:30-14:00

Title:ย Obesity and CVD: Deciphering a complex relationship

ย 

Click here to view session agenda.